546 related articles for article (PubMed ID: 23939548)
1. Advances in the treatment of neurofibromatosis-associated tumours.
Lin AL; Gutmann DH
Nat Rev Clin Oncol; 2013 Nov; 10(11):616-24. PubMed ID: 23939548
[TBL] [Abstract][Full Text] [Related]
2. Neurofibromatosis-related tumors: emerging biology and therapies.
Karajannis MA; Ferner RE
Curr Opin Pediatr; 2015 Feb; 27(1):26-33. PubMed ID: 25490687
[TBL] [Abstract][Full Text] [Related]
3. Mouse models of neurofibromatosis 1 and 2.
Gutmann DH; Giovannini M
Neoplasia; 2002; 4(4):279-90. PubMed ID: 12082543
[TBL] [Abstract][Full Text] [Related]
4. Neurofibroma and schwannoma.
Ferner RE; O'Doherty MJ
Curr Opin Neurol; 2002 Dec; 15(6):679-84. PubMed ID: 12447105
[TBL] [Abstract][Full Text] [Related]
5. Neurofibromatosis 2011: a report of the Children's Tumor Foundation annual meeting.
Kalamarides M; Acosta MT; Babovic-Vuksanovic D; Carpen O; Cichowski K; Evans DG; Giancotti F; Hanemann CO; Ingram D; Lloyd AC; Mayes DA; Messiaen L; Morrison H; North K; Packer R; Pan D; Stemmer-Rachamimov A; Upadhyaya M; Viskochil D; Wallace MR; Hunter-Schaedle K; Ratner N
Acta Neuropathol; 2012 Mar; 123(3):369-80. PubMed ID: 22083253
[TBL] [Abstract][Full Text] [Related]
6. 2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis.
Fisher MJ; Belzberg AJ; de Blank P; De Raedt T; Elefteriou F; Ferner RE; Giovannini M; Harris GJ; Kalamarides M; Karajannis MA; Kim A; Lázaro C; Le LQ; Li W; Listernick R; Martin S; Morrison H; Pasmant E; Ratner N; Schorry E; Ullrich NJ; Viskochil D; Weiss B; Widemann BC; Zhu Y; Bakker A; Serra E
Am J Med Genet A; 2018 May; 176(5):1258-1269. PubMed ID: 29681099
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis.
Blakeley JO; Plotkin SR
Neuro Oncol; 2016 May; 18(5):624-38. PubMed ID: 26851632
[TBL] [Abstract][Full Text] [Related]
8. CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies.
Widemann BC; Acosta MT; Ammoun S; Belzberg AJ; Bernards A; Blakeley J; Bretscher A; Cichowski K; Clapp DW; Dombi E; Evans GD; Ferner R; Fernandez-Valle C; Fisher MJ; Giovannini M; Gutmann DH; Hanemann CO; Hennigan R; Huson S; Ingram D; Kissil J; Korf BR; Legius E; Packer RJ; McClatchey AI; McCormick F; North K; Pehrsson M; Plotkin SR; Ramesh V; Ratner N; Schirmer S; Sherman L; Schorry E; Stevenson D; Stewart DR; Ullrich N; Bakker AC; Morrison H
Am J Med Genet A; 2014 Mar; 164A(3):563-78. PubMed ID: 24443315
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis types 1 and 2.
Yohay K
Neurologist; 2006 Mar; 12(2):86-93. PubMed ID: 16534445
[TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis and associated tumour suppressor genes.
Zwarthoff EC
Pathol Res Pract; 1996 Jul; 192(7):647-57. PubMed ID: 8880865
[TBL] [Abstract][Full Text] [Related]
11. Neurofibromatosis.
Gerber PA; Antal AS; Neumann NJ; Homey B; Matuschek C; Peiper M; Budach W; Bölke E
Eur J Med Res; 2009 Mar; 14(3):102-5. PubMed ID: 19380279
[TBL] [Abstract][Full Text] [Related]
12. Calpain-dependent proteolysis of NF2 protein: involvement in schwannomas and meningiomas.
Kimura Y; Saya H; Nakao M
Neuropathology; 2000 Sep; 20(3):153-60. PubMed ID: 11132929
[TBL] [Abstract][Full Text] [Related]
13. Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis.
Tamura R
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072574
[TBL] [Abstract][Full Text] [Related]
14. The neurofibromatosis type 2 gene is inactivated in schwannomas.
Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA
Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of NF2 and NF1 tumor suppressor genes in distinctive gastrointestinal nerve sheath tumors traditionally diagnosed as benign schwannomas: s study of 20 cases.
Lasota J; Wasag B; Dansonka-Mieszkowska A; Karcz D; Millward CL; Ryś J; Stachura J; Sobin LH; Miettinen M
Lab Invest; 2003 Sep; 83(9):1361-71. PubMed ID: 13679444
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromatosis 2.
Baser ME; R Evans DG; Gutmann DH
Curr Opin Neurol; 2003 Feb; 16(1):27-33. PubMed ID: 12544854
[TBL] [Abstract][Full Text] [Related]
17. Neurofibromatosis: part 2--clinical management.
Batista PB; Bertollo EM; Costa Dde S; Eliam L; Cunha KS; Cunha-Melo JR; Darrigo Junior LG; Geller M; Gianordoli-Nascimento IF; Madeira LG; Mendes HM; Miranda DM; Mata-Machado NA; Morato EG; Pavarino ÉC; Pereira LB; Rezende NA; Rodrigues Lde O; Sette JB
Arq Neuropsiquiatr; 2015 Jun; 73(6):531-43. PubMed ID: 26083891
[TBL] [Abstract][Full Text] [Related]
18. Neurofibromatosis.
McClatchey AI
Annu Rev Pathol; 2007; 2():191-216. PubMed ID: 18039098
[TBL] [Abstract][Full Text] [Related]
19. The path forward: 2015 International Children's Tumor Foundation conference on neurofibromatosis type 1, type 2, and schwannomatosis.
Blakeley JO; Bakker A; Barker A; Clapp W; Ferner R; Fisher MJ; Giovannini M; Gutmann DH; Karajannis MA; Kissil JL; Legius E; Lloyd AC; Packer RJ; Ramesh V; Riccardi VM; Stevenson DA; Ullrich NJ; Upadhyaya M; Stemmer-Rachamimov A
Am J Med Genet A; 2017 Jun; 173(6):1714-1721. PubMed ID: 28436162
[TBL] [Abstract][Full Text] [Related]
20. Genotype-Phenotype Correlations in Neurofibromatosis and Their Potential Clinical Use.
Bettegowda C; Upadhayaya M; Evans DG; Kim A; Mathios D; Hanemann CO;
Neurology; 2021 Aug; 97(7 Suppl 1):S91-S98. PubMed ID: 34230207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]